Shanghai Fosun Pharmaceutical Group Co Ltd represents a set of core values and a strong corporate philosophy. With a focus on innovation, integrity, and social responsibility, the company strives to deliver high-quality pharmaceutical products and healthcare services. Shanghai Fosun Pharmaceutical Group Co Ltd believes in fostering sustainable development and prioritizes the well-being of patients and the community. The company's dedication to excellence, patient-centric approach, and continuous research and development efforts make it a prominent player in the pharmaceutical industry. Shanghai Fosun Pharmaceutical Group Co Ltd exemplifies a commitment to quality, ethical practices, and making a positive impact on society.

The Shanghai Fosun Pharmaceutical Group Co Ltd primarily operates and has a significant presence in multiple countries and regions. The company is mainly active in China, where its headquarters is located. It also has a strong presence in various other regions and countries, including the United States, Europe, India, and Africa. Shanghai Fosun Pharmaceutical Group Co Ltd focuses on expanding its global footprint through strategic partnerships, collaborations, and acquisitions. With its diversified portfolio and global operations, the company continues to deliver innovative healthcare solutions and contribute to the well-being of people worldwide.

Shanghai Fosun Pharmaceutical Group Co Ltd has achieved several significant milestones in its history. The company has demonstrated consistent growth and expansion, becoming one of the leading pharmaceutical companies in China. It has successfully developed and marketed various innovative drugs, contributing to improved healthcare outcomes for patients. Shanghai Fosun Pharmaceutical Group Co Ltd has also made strategic acquisitions and formed partnerships to strengthen its market presence both domestically and internationally. Additionally, the company has received recognition for its commitment to research and development, as well as its contributions to healthcare philanthropy. These achievements make Shanghai Fosun Pharmaceutical Group Co Ltd a formidable player in the pharmaceutical industry.

Shanghai Fosun Pharmaceutical Group Co Ltd, commonly known as Fosun Pharma, is a leading Chinese pharmaceutical company. Established in 1994, the company has a rich history and a strong background in the healthcare industry. Fosun Pharma focuses on research, development, manufacturing, and distribution of a wide range of pharmaceutical products, including prescription drugs, over-the-counter medicines, and medical devices. Over the years, Fosun Pharma has expanded its presence globally and has become one of the largest comprehensive healthcare groups in China. With a commitment to innovation and high-quality products, Shanghai Fosun Pharmaceutical Group Co Ltd continues to make significant contributions to the advancement of healthcare worldwide.

The main competitors of Shanghai Fosun Pharmaceutical Group Co Ltd in the market include multinational pharmaceutical companies such as Johnson & Johnson, Pfizer, Novartis, and GlaxoSmithKline. These competitors are well-established players in the global pharmaceutical industry and offer a wide range of products and services similar to Shanghai Fosun Pharmaceutical Group. As Shanghai Fosun Pharmaceutical Group aims to expand globally and capture a larger market share, it faces strong competition from these industry giants. However, Shanghai Fosun Pharmaceutical Group has its unique strengths, product portfolio, and innovative strategies to differentiate itself and gain a competitive advantage in the market.

Shanghai Fosun Pharmaceutical Group Co Ltd is primarily active in the pharmaceutical industry.

The business model of Shanghai Fosun Pharmaceutical Group Co Ltd focuses on various aspects of the pharmaceutical industry. As a leading healthcare company, it engages in research and development, manufacturing, sales, and distribution of pharmaceutical products. Shanghai Fosun Pharmaceutical Group Co Ltd is committed to promoting innovation and improving the accessibility of healthcare products and services. It operates through segments such as pharmaceutical manufacturing, research and development, distribution and retail, and medical services. By leveraging its strong industry expertise and strategic partnerships, Shanghai Fosun Pharmaceutical Group Co Ltd aims to contribute to the advancement of healthcare and provide high-quality medical solutions to customers worldwide.

مُعامل القيمة السوقية إلى الأرباح لـ Shanghai Fosun Pharmaceutical Group Co هو ٢١٫٠١.

مُعامِل القيمة إلى المبيعات Shanghai Fosun Pharmaceutical Group Co هو ١٫٣٢.

نقاط جودة AlleAktien لـ Shanghai Fosun Pharmaceutical Group Co هي 4/10.

المتوقعة Shanghai Fosun Pharmaceutical Group Co الإيرادات هي ٤٤٫٨٨ مليارات CNY.

صافي الربح المتوقعة Shanghai Fosun Pharmaceutical Group Co هو ٢٫٨٢ مليارات CNY.

The Shanghai Fosun Pharmaceutical Group Co Ltd is a leading company in the development, manufacturing, and marketing of pharmaceutical products and medical services. The business model is based on a diversified portfolio of business activities focused on various segments of the healthcare industry. The company's first division is the manufacturing of pharmaceutical products. Shanghai Fosun Pharma produces a wide range of medical products, including drugs, diagnostics, and medical devices. The company specializes in innovative drug manufacturing to offer high-quality medical solutions to its customers, with a strong emphasis on product quality. Another important division is research and development. Shanghai Fosun Pharma invests significantly in researching and developing new drugs and therapies. The company collaborates closely with international partners to develop innovative technologies and products that meet market needs. In addition to these activities, the company also operates hospitals, healthcare centers, and care facilities. Shanghai Fosun Pharma is a leading provider of high-quality healthcare services in China. The company strives to offer its customers a comprehensive range of services focused on the needs of patients. Furthermore, the group also has a subsidiary, Fosun Industrial Co Ltd, specializing in the manufacturing and marketing of chemicals and plastic products. This perfectly complements the company's portfolio and enables it to serve more customers. The company also offers various health products, including dietary supplements, medical aids, and wellness products. These products are sold in the company's own pharmacies as well as retail pharmacies nationwide. Shanghai Fosun Pharma also operates in overseas markets, with branches in various countries around the world. The company aims to bring product quality and innovation to the global market in order to make them accessible to an even larger part of society. In summary, the business model of Shanghai Fosun Pharmaceutical Group Co Ltd is based on innovation and differentiation through research and development, manufacturing, and distribution of drugs, medical services, and products. The company has a strong presence in the healthcare market and delivers world-leading products and services.

يوزع Shanghai Fosun Pharmaceutical Group Co أرباحًا قدرها ٠٫٥٦ CNY من خلال عمليات توزيع موزعة على مدار السنة.

لا يمكن حساب الأرباح السنوية لـ Shanghai Fosun Pharmaceutical Group Co في الوقت الحالي أو أن الشركة لا توزع أرباحًا.

الرمز الدولي للأوراق المالية الخاص بـShanghai Fosun Pharmaceutical Group Co هو CNE000000X38.

الرمز المُختصر لـ Shanghai Fosun Pharmaceutical Group Co هو 600196.SS.

خلال آخر 12 شهراً، دفعت Shanghai Fosun Pharmaceutical Group Co توزيعات أرباح بقيمة ٠٫٤٢ CNY . وهذا يعادل عائد توزيعات أرباح يقارب ١٫٨٩ %. ومن المتوقع أن تدفع Shanghai Fosun Pharmaceutical Group Co خلال الـ12 شهراً القادمة توزيعات أرباح تقدر بـ٠٫٤٤ CNY.

نسبة توزيعات الأرباح الحالية لـ Shanghai Fosun Pharmaceutical Group Co هي ١٫٨٩ %.

Shanghai Fosun Pharmaceutical Group Co يدفع توزيعات أرباح ربع سنوية. يتم توزيعها في الأشهر أغسطس, يوليو, سبتمبر, سبتمبر.

Shanghai Fosun Pharmaceutical Group Co دفعت توزيعات الأرباح كل عام خلال الـ23 سنوات الماضية.

يُتوقع خلال الـ12 شهرًا القادمة توزيع أرباح بقيمة ٠٫٤٤ CNY. وهذا يعادل عائد توزيعات أرباح قدره ٢٫٠٠ %.

Shanghai Fosun Pharmaceutical Group Co يُصنف ضمن قطاع 'الصحة'.

لكي تستلم آخر توزيعات أرباح بقيمة ٠٫٢٧ CNY من Shanghai Fosun Pharmaceutical Group Co المُعلن عنها في ٦‏/٨‏/٢٠٢٤، كان يجب أن تمتلك السهم في محفظتك قبل تاريخ الاستحقاق السابق في ٦‏/٨‏/٢٠٢٤.

تم توزيع آخر دفعة من الأرباح بتاريخ ٦‏/٨‏/٢٠٢٤.

في العام 2023، وزعت Shanghai Fosun Pharmaceutical Group Co ٠٫٥٦ CNY كأرباح أسهم.

يتم توزيع أرباح Shanghai Fosun Pharmaceutical Group Co بالعملة CNY.